DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Zhu AX, Finn RS, Mulcahy MF , et al.
A phase II study of ramucirumab as first-line monotherapy in patients with advanced hepatocellular carcinoma.
J Clin Oncol 2010;
28 (15S) Abstract 4083
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.